BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35256266)

  • 1. Active surveillance of low-risk papillary thyroid microcarcinoma.
    Sugitani I
    Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
    Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 4. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
    Ito Y; Miyauchi A
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
    Miyauchi A; Ito Y; Oda H
    Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
    Ito Y; Miyauchi A
    Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discussion on how to optimize active surveillance for low-risk papillary thyroid microcarcinoma in China].
    Xue S; Wang PS; Lu QY; Chen G
    Zhonghua Wai Ke Za Zhi; 2023 Jun; 61(6):462-466. PubMed ID: 37088477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
    Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
    Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.
    Issa PP; Munshi R; Albuck AL; Omar M; Abu Alhuda RF; Metz T; Hussein M; Shama M; Lee GS; Toraih E; Kandil E
    Am J Otolaryngol; 2023; 44(6):103994. PubMed ID: 37607459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance.
    Sasaki T; Miyauchi A; Fujishima M; Ito Y; Kudo T; Noda T; Sano T; Kishi T; Nakamura T
    Thyroid; 2023 Feb; 33(2):186-191. PubMed ID: 36205580
    [No Abstract]   [Full Text] [Related]  

  • 11. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
    Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
    Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
    [No Abstract]   [Full Text] [Related]  

  • 12. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma.
    Miyauchi A; Ito Y
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):215-226. PubMed ID: 30717903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary thyroid microcarcinoma: optimal management versus overtreatment.
    Walgama E; Sacks WL; Ho AS
    Curr Opin Oncol; 2020 Jan; 32(1):1-6. PubMed ID: 31633497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
    Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 16. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
    Zhang H; Zheng X; Liu J; Gao M; Qian B
    Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
    Leboulleux S; Tuttle RM; Pacini F; Schlumberger M
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):933-942. PubMed ID: 27550849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Brito JP; Ito Y; Miyauchi A; Tuttle RM
    Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
    Sawka AM; Ghai S; Tomlinson G; Baxter NN; Corsten M; Imran SA; Bissada E; Lebouef R; Audet N; Brassard M; Zhang H; Gupta M; Nichols AC; Morrison D; Johnson-Obeski S; Prisman E; Anderson D; Chandarana SP; Ghaznavi S; Jones J; Gafni A; Matelski JJ; Xu W; Goldstein DP;
    Front Endocrinol (Lausanne); 2021; 12():686996. PubMed ID: 34194396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary microcarcinoma of the thyroid gland: current controversies and management.
    Rovira A; Nixon IJ; Simo R
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):110-116. PubMed ID: 30844924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.